Journal of Assisted Reproduction and Genetics

, Volume 12, Issue 9, pp 599–605 | Cite as

Antiovarian antibodies and their effect on the outcome of assisted reproduction

  • Meenakshi Narayanan
  • P. S. R. Murthy
  • S. A. Munaf
  • L. C. P. Shah
  • M. D. Kini
Clinical Assisted Reproduction

Abstract

Purpose

To compare the presence in levels of antiovarian antibodies (AOAb) in the pre- and postovulatory stage from serum of infertile patients undergoing intrauterine insemination (IUI) or in vitrofertilization (IVF) with outcome of the procedures.

Results

Serum from 36 women undergoing IUI, 36 women undergoing IVF and 25 fertile, healthy controls were assayed for the presence of AQAb by a commercially available ELIS A kit. AOAb was positive in 59.7% of infertile women, while none of the fertile controls were positive for AOAb. The levels of these antibodies increased as the patient age and the number of treatment attempts increased. Though the presence of AOAb did not affect oocyte recovery rate, it resulted in decreased fertilization rate, cleavage rate, and pregnancy rate in infertile women.

Conclusions

Our studies suggest that AOAb may be a cause of infertility and presence of these antibodies could have adverse effects on the outcome of assisted reproductive techniques.

Key words

antiovarian antibodies cleavage rate fertilization rate infertility pregnancy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shibahara H, Burkman IJ, Isojima S, Alexander NJ: Effects of sperm immobilizing antibodies on sperm-zona pellucida tight binding. Fertil Steril 1993;60:533–539PubMedGoogle Scholar
  2. 2.
    Moncayo-Nevada H, Moncayo R, Benz R, Rer. Nat, Wolf A, Lauritzen Ch: Organ-specific antibodies against ovaries in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1989;160:1227–1229PubMedGoogle Scholar
  3. 3.
    De Moraes Ruehsen M, Blizzard RM, Garcia-Bunnel R, Jones GS: Autoimmunity and ovarian failure. Am J Obstet Gynecol 1972;112:693–703PubMedGoogle Scholar
  4. 4.
    Coulam CB, Kempers RD, Randall RV: Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 1981;36:238–240PubMedGoogle Scholar
  5. 5.
    Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, De Cherny A: Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990:70:69–75PubMedGoogle Scholar
  6. 6.
    Damewood MD, Zacur HA, Hoffman GJ, Rock JA: Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 1986;68:850–854PubMedGoogle Scholar
  7. 7.
    Irvine WJ, Chan MMW, Scarth K, Kolb FO, Hartog M, Balyss RIS, Drury MI: Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1967:2:883–884Google Scholar
  8. 8.
    Ahonen P, Miettinen A, Perheentupa J: Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987;64:494–498PubMedGoogle Scholar
  9. 9.
    Confino E, Harlow L, Gleicher N: Peritoneal fluid and serum antibody levels in patients with endometriosis. Fertil Steril 1990:53:242–245PubMedGoogle Scholar
  10. 10.
    Mathur S, Peress MR, Williamson HO, Youmans CD, Maney SA, Garvin AJ, Rust PF, Fudenberg HH: Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982;50:259–266PubMedGoogle Scholar
  11. 11.
    Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen Ch: Ovarian failure and autoimmunity: Detection of autoantibodies directed against both the unoccupied leutinizing hormone/human chorionic gonadotropin receptor and the hormone receptor complex of bovine corpus luteum. J Clin Invest 1989:84:1857–1865PubMedGoogle Scholar
  12. 12.
    Veeck LL: Atlas of the human oocyte and early conceptus, CL Brown (ed). Baltimore, Williams and Wilkins, pp 5–139Google Scholar
  13. 13.
    Mignot MH, Drexhage HA, Kliengold M, Van de Plassche-Boers FM, Ramanth Rao B, Shoemaker J: Premature ovarian failure. II: Consideration of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol 1989;30:67–82PubMedGoogle Scholar
  14. 14.
    Moncayo R, Moncayo H, Dupont O: Immunological risks of IVF. Lancet 1990;335:180Google Scholar
  15. 15.
    Barbarino-Monnier P, Gobert B, Giullet-Rosso F, Béné MC, Laudes P, Faure G: Antiovarian antibodies, repeated attempts and outcome of in vitro fertilization. Fertil Steril 1991:56:928–932PubMedGoogle Scholar
  16. 16.
    Gobert B, Barbarino-Monnier P, Giullet-May F, Béné MC, Faure G: Antiovarian antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation. J Reprod Fertil 1992;96:213–218PubMedGoogle Scholar
  17. 17.
    Jenkins JM, Wheatcroft N, Arthur I, Astori K, Masson G, Cooke I, Wheetman T: Ovarian antibodies may not have adverse influence on the response to gonadotropin stimulation preceding IVF. Hum Reprod 1994;9 (Suppl 3) Abs FC17, pp 13–14PubMedGoogle Scholar
  18. 18.
    Moncayo R, Moncayo HE: A new endocrinological and immunological syndrome in systemic lupus erythematosus: elevation of human chorionic gonadotropins and antibodies directed against ovary and endometrial antigens. Lupus 1995:7:39–45Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Meenakshi Narayanan
    • 1
  • P. S. R. Murthy
    • 1
  • S. A. Munaf
    • 1
  • L. C. P. Shah
    • 1
  • M. D. Kini
    • 1
  1. 1.I.V.F. and Infertility UnitAlmana General HospitalKingdom of Saudi Arabia

Personalised recommendations